Effect of ciprofol/propofol on short and medium-term renal function in patients undergoing renal transplantation

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200064881

Enrollment

Unknown

Registered

2022-10-20

Start date

2022-10-20

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage renal disease

Interventions

Propofol Group :Propofol

Ciprofol Group :Ciprofol

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. First-time cadaver kidney transplant; 2. Gender is not limited, ASA classification ?~?, aged 18 ~ 65 years, BMI18 ~ 30 kg/m^2; 3. Regular preoperative dialysis treatment; 4. Able to understand the procedures and methods of this study, willing to sign informed consent and strictly follow the clinical study protocol to complete this study.

Exclusion criteria

Exclusion criteria: 1. Suffering from liver, mental and nervous system diseases; 2. Coagulopathy, heart failure, respiratory failure; 3. Long-term use of sedatives or antidepressants; 4. Pregnant or lactating patients; 5. Unable to communicate and cooperate.

Design outcomes

Primary

Measure	Time frame
Urea nitrogen;Creatinine;Cystatin C;Glomerular filtration rate;Urine volume;	—

Countries

China

Contacts

Public ContactDu Xueke

Department of Anesthesiology, the Second Affiliated Hospital of Guangxi Medical University

46699644@qq.com+86 13707880675

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026